The New Mexico Biotechnology & Biomedical Association (NMBio) Board of Directors is a volunteer group of scientists, academics and other professionals dedicated to the advancement of bioscience in New Mexico and the promotion of New Mexico’s capabilities internationally. The NMBio membership elects eight innovative thinkers and community leaders to the board every year. During their two-year terms, directors are involved in NMBio-sponsored programs and events, policy development, and a variety of committee assignments.
The Executive Director provides leadership and guidance to expand and represent the organization to the community.
Board of Directors
Director, Product Management
TriCore Reference Labs
Mr. VanNess works integrally with TriCore’s team responsible for building and releasing its new business, Diagnostic Optimization. TriCore is attempting to redefine its position in the healthcare market and Mr. VanNess is an essential member in assuring the right products are brought to market to assure customers find it valuable, useful, and assists the volume to value shift within healthcare. He evaluates new opportunities, directs the strategy, and ensures overall product success by working closely with customers and team members. Previously he was the Clinical Coordinator at VisionQuest Biomedical and released is commercial teleretinal screening application. Additionally, Mr. VanNess is the innovator and project manager of an SBIR award to develop a new device for assessing mild traumatic brain injury. He holds a MS in Pharmaceutical Sciences from the University New Mexico, and a BS in Environmental Health at New Mexico State University.
NMBio Vice President
Lovelace Scientific Resources, Inc.
Darlene Harbour, BSN, RN, CCRC, is President of Lovelace Scientific Resources, Inc. LSR is,the Clinical Research Division of the Lovelace Respiratory Research Institute. She is a Registered Nurse who has been working in clinical research and in multiple health disciplines for over 25 years. She also serves as program manager on clinical research projects for the military, sponsored by the Federal Government and research projects sponsored by the State of New Mexico. Prior to her clinical research work, she worked in various health care inpatient and outpatient settings throughout the State of NM. She currently manages clinical research sites within LSR and also works in protocol development and study design, implementing and executing clinical research projects, while ensuring regulatory compliance. She serves as a member of the Board of Directors for the Veterans Administration affiliated non-profit, the Biomedical Research Institute of New Mexico (BRINM) in Albuquerque.
NMBio Vice President
CEO and Chief Economic Development Officer
Lisa Kuuttila joined STC.UNM (STC), the University of New Mexico’s technology-transfer program, as President & CEO in 2003. She is currently CEO & Chief Economic Development Officer of the organization. She works with the STC.UNM Board of Directors in developing strategies for implementing STC’s vision to play a vital role in New Mexico’s economic development and to be a leader in technology commercialization. Under her leadership, STC.UNM is substantially growing its program using the Rainforest model to develop an innovation ecosystem in New Mexico. In 2013, STC.UNM was tasked by the University with implementing its economic development initiatives under Lisa’s leadership.
Ms. Kuuttila has more than 30 years of prior leadership experience in technology commercialization and licensing. This includes positions as Assistant Vice President for Technology Commercialization at Purdue Research Foundation; Director, Technology Commercialization, University of Georgia; and Director, Office of Technology Commercialization, Center for Advanced Technology Development, Iowa State University. Her prior experience also includes a consulting practice that provided strategic marketing and technology-transfer consulting services for a wide variety of well-known technology corporations, universities and foundations, including Stanford University. She began her career in industry in several engineering and technology-marketing positions. Lisa received a B.S. Electrical Engineering from the University of Michigan and an M.S. in Public Administration from Iowa State University. She is also a graduate of the Venture Capital Institute.
NMBio Vice President
Arrowhead Park, Arrowhead Center at New Mexico State University
Wayne is the Executive Director of the Arrowhead Research Park at New Mexico State University, a 175-acre facility currently in development of a healthcare and medical technology industry campus centered around NMSU’s medical research capacities, the Burrell College of Osteopathic Medicine, the Arrowhead Park High School Medical Academy, and a number of tenant partners. The Park provides is a major component of NMSU’s economic development mission.
Wayne is a 1980 graduate of New Mexico State University’s Industrial Engineering program, and a 1994 NMSU Ingeniero Imminente awardee. He has over 30 years of experience in semiconductor manufacturing, high purity gas and chemical production, construction management, and economic development consulting. He has served in a variety of capacities contributing to the successful startup of Spaceport America and the growing commercial space industry, having represented both the New Mexico Spaceport Authority and client/tenant interests. He’s currently serving on the Borderplex Alliance Life Sciences committee
Peacock Law P.C.
jvilven AT PeacockLaw DOT com
Janeen is Elections Committee Chair for NMBio
Janeen Vilven-Doggett practices in the areas of litigation and transactional matters. She is a member of the New Mexico bar and a registered patent attorney. Dr. Vilven-Doggett received her B.A. in Biology from Baylor University in 1986 and her Ph.D. in Biomedical Sciences from the University of New Mexico in 1997. She received her J.D. (cum laude) from the University of New Mexico School of Law in 2001.
Dr. Vilven-Doggett has experience both as an attorney and as a research scientist. Janeen is a well-known and experienced intellectual property practioner and has been so recognized in Best Lawyers in America. Prior to becoming an attorney, she spent about 13 years as a research scientist at both Baylor College of Medicine (Department of Molecular Physiology and Biophysics), and the University of New Mexico Health Sciences Center (Department of Pediatrics and Department of Pathology). for a comprehensive listing of Dr Vilven Doggett’s publications, please visit here.
Director of Operations
michael AT massbiolab DOT com
Michael is a graduate of the University of New Mexico’s Anderson Schools of Management with a BBA in Financial Management. Vickers manages the day to day operations for Maas Biolab, LLC and oversees the company’s several ongoing drug development projects including good manufacturing practices production of Maas Biolab’s cyclosporine formuation Mitogard(R), good laboratory practices dose range finding toxicology studies and compilation of an Investigational New Drug (IND) application under the company’s current SBIR project. Mr. Vickers co-authored Maas Biolab’s successful grant proposals including a National Insitutes of Health (NIH) fast track SBIR grant as well as a Fort Detrick Tech Transfer Initiative grant. Michael also managed the company’s Defense Threat Reduction Agency (DTRA) contract studying the brain penetration and effectiveness of cyclosporine in models of nerve agent exposure.
T.J. Cook is a creative, strategic innovator specializing in strategy and team management for early-stage tech startups. As Fund Manager of ABQid at CNM Ingenuity, Cook helps early-stage companies with high growth potential accelerate traction through seed capital and connectivity to leading programs like Activate New Mexico, Hyperspace Challenge, and pitch events like Ski Lift Pitch and Balloon Pitch.
Previously as CEO of CauseLabs, a certified Benefit Corporation, Cook helped design a rapid approach to problem solving that launched more than 100 digital solutions for companies like LEGO and IDEO, while assembling an award-winning team of 15 strategists, designers, and engineers around the world to prototype and build breakthroughs.
Cook has more than 18 years’ experience on the forefront of emerging technologies and entrepreneurial strategies and uses his systems perspective to provide guidance and support
to numerous early stage efforts. He sits on the board of ABQid, Conveners.org, and The Grants Collective, and advises aspiring entrepreneurs of all ages in order to help them accelerate their impact. He lives in Albuquerque with his wife, three children, and trail-running partner, a terrier mix named Lady.
Terry Dunlay is a seasoned life science entrepreneur with over 30 years of experience in technology development and commercialization. He is the founder and former CEO of IntelliCyt Corporation, a developer of high throughput cell analysis systems, which was acquired by Sartorius AG in 2016. IntelliCyt built its cutting edge products based on technology invented at and licensed from the University of New Mexico. Prior to founding IntelliCyt, Terry was co-founder of Cellomics, based in Pittsburgh, PA, a developer of high content cell screening systems which was acquired by Thermo Fisher in 2005. Prior to Cellomics, Terry was part of two cell image analysis startups associated with Carnegie Mellon University as founder and CEO of Biological Detection, Inc. and Vice President of Engineering at Biological Detection Systems. Terry received his initial hands-on entrepreneurial training in the life sciences as an early employee at Cytyc Corporation in Boston, MA which had a very successful IPO.
Before getting into the life sciences, Terry worked as an engineer developing computer vision algorithms for some of the earliest demonstrated self-driving vehicles at Lockheed Martin and developing industrial automation systems at PPG Industries. Terry has a BS and an MS in Electrical Engineering. He holds 15 patents in the area of cell-based screening instrumentation and informatics.
Dr. Tom Kieft
Professor of Biology
New Mexico Institute of Mining and Technology
Dr. Tom Kieft is a microbiologist in the Biology Department at New Mexico Institute of Mining and Technology (New Mexico Tech). He has over 40 years experience in biological sciences that includes employment early in his career as a clinical microbiologist, 30 years of undergraduate and graduate teaching (courses in general microbiology, medical microbiology, and immunology), and extensive research in environmental microbiology, animal microbiomes, and detection of pathogens in the environment. Kieft has served as Chair of Biology Department and as Associate Vice-President for Research and Economic Development at New Mexico Tech, and he’s currently the Chair New Mexico Tech’s new interdisciplinary Ph.D. Program in Biotechnology.
Chief Operating Officer and Chief Commercialization Officer
Myrexis and Myriad Pharmaceuticals
Wayne Laslie has more than 30 years of experience in pharmaceutical commercialization. He served as the Chief Operating Officer and Chief Commercialization Officer for Myrexis and Myriad Pharmaceuticals, drug development companies headquartered in Salt Lake City, Utah. Most recently, Wayne served as the Chief Executive Officer and President of Zocere, Inc.; he continues to serve on the boar’s of directors. Previously, he was Head of the commercial group at Otsuka America Pharmaceuticals, where he oversaw the launch of new drugs, including Pletal and Abilify. Wayne held senior commercial positions in Europe and the United States with the predecessor companies of Sanofi as well as clinical and marketing positions with Pfizer.
Richard S. Larson, MD, PhD
Executive Vice Chancellor and Vice Chancellor for Research
University of New Mexico Health Sciences Center
rlarson AT salud.unm DOT edu
Dr. Larson is the recipient of the College of American Pathology Lansky Award for his leadership in and contribution to the practice of pathology, UNM Regents Lectureship for contribution to UNM, and American Cancer Society Designated National Investigator for the Coaches against Cancer and Hoops for Lymphoma/Leukemia. One of his publications was chosen as manuscript of the year and appeared in the 2002 Yearbook of Pathology and Laboratory Medicine. Dr. Larson received both his MD and PhD from Harvard University. He did his residency training at Washington University at St. Louis, and his fellowship training at Vanderbilt University. He is a board-certified physician. He maintains a peer-reviewed, funded laboratory as well as his administrative duties. His research interests include biochemical mechanisms of inflammation, viral detection, and new drug discovery. He has published over 80 manuscripts involving basic science, clinical, and translational research. His book Bioinformatics and Drug Discovery was published by Humana Press in 2005. He is active in national cooperative groups, and research organizations. He was the founder of Cancer Services of New Mexico. He is a Chairman of the Board of Directors for TriCore Reference Laboratories as well as a member of the National Center for Genome Resources Board of Directors.
Director of Corporate Development
Paul Laur is the Director of Corporate Development for Pebble Labs USA. Pebble Labs is a biotechnology company developing solutions to safely and sustainably increase natural crop yield and food security for better human and planetary health. Our mission is to develop breakthrough disruptive technologies that address the greatest agriculture, aquaculture, and environmental challenges facing the globe. He completed his Master’s Degree at St. John’s College in Santa Fe, NM and his B.S. at California Maritime Academy.
Prior to joining Pebble Labs, Paul founded sustainability oriented Spartina Biotechnologies, Eldorado Biofuels, and NM organic Santa Fe Cider Company; and was Director of Operations at Anguilla Rums. Paul holds a USCG Master Mariner’s license and spent over twenty years sailing around the world on ocean racing sailboats and cargo ships before settling down to raise his family in Santa Fe, NM.
General Manager and Site Head
AMRI Oso Biopharmaceuticals Manufacturing
David Lee is the General Manager and Site Head at AMRI in Albuquerque. He manages all aspects of drug products at the CMO site and is responsible for a $35 million annual operating budget while generating more than $60 million in revenues. He supervises more than 300 employees and oversees the manufacturing of a wide range of parenteral products for a diverse customer base that includes large pharmaceutical companies and small start-ups. For 20 years, he worked for Amgen, Inc. in various high level positions focused on operations, validation and quality control.
President and CEO
Santa Fe Business Incubator
A recognized leader in Business Incubation and entrepreneurial development, Marie Longserre has been the President and CEO of the Santa Fe Business Incubator (SFBI) in Santa Fe, New Mexico since its inception in 1997. Under her guidance SFBI added a state of the art shared Bio-Science Lab to the facility in 2014. Marie was twice elected to the Board of the National Business Incubation Association (NBIA) and was Board Chair in 2011-2012. She served on New Mexico Small Business Investment Council for two terms and as NMSBIC Treasurer. She currently represents New Mexico on the Community Development Advisory Council at the Federal Reserve Bank of Kansas City.
Antonio Redondo, PhD
Richard P. Feynman Center for Innovation, Los Alamos National Laboratory
In 2018, Antonio “Tony” Redondo was appointed head of the Richard P Feynman Center for Innovation, the organization at Los Alamos National Laboratory in charge of technology transfer. His recent interests in research have focused on modeling soft matter and fluid systems.
He came to Los Alamos National Laboratory as a Technical Staff Member in the Electronics and Electrochemical Materials and Devices Group in 1983 where he researched electrochemical fuel cells and semiconductor devices. He has led a team of scientists at Los Alamos to design a catalytic converter for a new generation of green automobiles. This project involved collaborations with three other national laboratories and the research organizations at General Motors, Ford and Chrysler. In March 1997 Antonio received a Medal for Technical Accomplishment from Vice-President Al Gore for his contributions to this project. He joined LANL’s Theoretical Division in 1994 as Group Leader of the Theoretical Chemistry and Molecular Physics Group.
In 2000, Dr. Redondo started to work on theoretical biology problems, particularly cell signaling and immunology. During 2005 and 2006 he was Group Leader of the Theoretical Biology and Biophysics Group, also in the Theoretical Division, and became Division Leader in 2006. In 2015 he returned to full-time research and was appointed Senior Scientist in the Theory, Simulation and Computation Directorate. He has been an Adjunct Professor in the Computational Science Research Center at San Diego State University and in the Chemical Engineering Department at the University of California at Santa Barbara. He is a Fellow of the American Association for the Advancement of Science and the World Technology Network. Dr. Redondo received a B.Sc. in Physics from Utah State University in 1971 and a M.Sc. and Ph.D.in Applied Physics from the California Institute of Technology in 1972 and 1977, respectively.
Stuart Rose, PhD
The BioScience Center
stuart AT thebiosciencecenter DOT com
Dr. Rose has over 40 years of experience in the pharmaceutical industry. Prior to establishing The BioScience Center in 2012, he served as founder and President/CEO of Oso Biopharmaceutical Manufacturing, a contract manufacturing organization for injectable pharmaceuticals.
Before founding Oso Biopharmaceutical, he held executive positions with Penick Corporation (President/CEO), ICN – now Valeant – Pharmaceuticals (Vice President of Worldwide Manufacturing and VP/GM of ICN Europe), and Par Pharmaceuticals (Senior VP). He spent the majority of his early career with American Cyanamid’s pharmaceutical arm, Lederle Laboratories, where he rose to Vice President of International Manufacturing and Logistics.
Dr. Rose is also a Director of Agilvax, a start-up entity with a novel platform for the development of vaccines; a Director of Oligocide, a start-up developing antimicrobial chemical compounds that attract and then kill bacteria, viruses and some fungi; and an investor/advisor in a number of other biotechnology start-ups. He holds a Ph.D. in Chemistry from Wayne State University in Detroit, Michigan.
Director of State Government Affairs
Brian Shank currently serves as Director of State Government Affairs for Novo Nordisk, an International biopharmaceutical company focused on work in Diabetes, Obesity, and Hemophilia Care. He currently covers NM in additional to seven other states and his experience includes 25+ years of Government affairs work at the Federal and State level representing the pharmaceutical and biotech industry, non-profit health associations, and government.
Immediately prior to Novo Nordisk, Brian worked for 4 other biopharmaceutical companies including Shire, AstraZeneca, Amgen, and TAP Pharmaceuticals and has covered all 50 states during his tenure in these roles. He held positions at the State level in Louisiana serving in public affairs capacities for the Louisiana State Medical Society, Louisiana Dental Association, and Medicare Peer Review Organization. Brian began his career working at the Federal Level in DC for a Congressional House member on Capitol Hill.
He is broadly affiliated with National and State Health and Legislative-Membership organizations with additional previous experience working on two Gubernatorial campaigns and one Congressional election. Brian holds a Masters Degree in Mass Communication/Political Communication from Louisiana State University and undergraduate degrees in Economics and Political Science. Brian resides in Colleyville, TX and is married with two children and an avid fitness enthusiast and live music aficionado.
Myrriah Tomar, PhD
Director, Office of Science and Technology
New Mexico Economic Development Dept
Myrriah Tomar is the Director of the Office of Science and Technology for the New Mexico Economic Development Department. She completed her Ph.D. in Molecular Biology at the University of Colorado Anschutz Medical School and her B.S. in Biochemistry from the University of New Mexico. Shortly after graduating with her Ph.D., Myrriah worked with the start-up company Safewhite Inc. as an Associate Scientist serving to transition their core technology into a product. She was awarded a post-doctoral fellowship by The Ohio State University for her research on obesity-induced pancreatic cancer.
Prior to her role at the State of New Mexico, Myrriah worked in the office of technology transfer at Rice University evaluating faculty invention disclosures for novelty and commercial potential.
As Executive Director, Gregory R. Byrnes works on behalf of the New Mexico Biotechnology and Biomedical industry to advocate for its support, accelerate its growth, promote its economic value to members and raise its visibility across the state as well as nationally.
Byrnes career spans 35 years as a journalist, economic development professional, association executive, entrepreneur and consultant. A nationally recognized leader in the field of economic development, Byrnes marketed the greater Philadelphia region as a hub for the life sciences and health care industries in his prior roles as director of Economic & Business Development for PECO Energy and President of the Philadelphia Developers Alliance, a consortium of 21 businesses and the City of Philadelphia.
Byrnes was Vice President of Membership and Business Development as well as a consultant to the Pennsylvania Bio Association. More recently, he served as Director of Corporate Projects for Atlanta-based Conway Data and Site Selection magazine. His consulting assignments include assisting the Chester County Economic Development Council (CCEDC) in strategic planning and fund raising for the county’s Keystone Innovation Zone, which was created to support young entrepreneurial firms in the biotech, information technology and alternative energy sectors. He has served on more than a dozen local, state, regional and national boards of directors, including the Urban Land Institute, Eastern Technology Council, CoreNet Global, and the Team Pennsylvania Foundation.